overeating on glp 1 I Thought GLP-1s Would Cure My Eating Disorder. They Made It Even Worse Are You On a GLP-1
Description
In the SURMOUNT 1 trial, tirzepatide 15 mg/week with general nutritional instructions produced a 20.9% reduction in body weight from baseline (vs
DM is a pro-atherogenic factor that induces atherosclerosis development and/or accelerates its progression through a multifactorial process
Research shows that GLP-1 receptor agonists maintain their ability to reduce appetite and improve blood sugar control even when steroids are present
The Lancet , 398(10313), 1811-1824
